Download Now: 7 Unstoppable Growth Engines of India's $10 Trillion Bull Run...
Here is the latest financial fact sheet of MERCURY LAB.. For more details, see the MERCURY LAB. quarterly results and MERCURY LAB. share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 2.1 |
No. of shares | m | 1.20 |
1 Week | % | 0.4 |
1 Month | % | 8.2 |
1 Year | % | 43.0 |
52 week H/L | Rs | 1,303.0/535.1 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
MERCURY LAB. EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 459 | 350 | 768 | 937 | 1,000 | |
Low | Rs | 300 | 212 | 267 | 456 | 390 | |
Sales per share (Unadj.) | Rs | 462.7 | 477.2 | 571.7 | 482.7 | 627.8 | |
Earnings per share (Unadj.) | Rs | 23.6 | 26.9 | 44.5 | 29.7 | 46.5 | |
Diluted earnings per share | Rs | 23.6 | 26.9 | 44.5 | 29.7 | 46.5 | |
Cash flow per share (Unadj.) | Rs | 37.2 | 42.5 | 60.5 | 50.1 | 67.2 | |
Dividends per share (Unadj.) | Rs | 1.50 | 2.00 | 3.50 | 3.50 | 3.50 | |
Adj. dividends per share | Rs | 1.50 | 2.00 | 3.50 | 3.50 | 3.50 | |
Avg Dividend yield | % | 0.4 | 0.7 | 0.7 | 0.5 | 0.5 | |
Book value per share (Unadj.) | Rs | 241.4 | 266.5 | 307.5 | 335.9 | 380.2 | |
Adj. book value per share | Rs | 241.4 | 266.5 | 307.5 | 335.9 | 380.2 | |
Shares outstanding (eoy) | m | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 | |
Price / Sales ratio | x | 0.8 | 0.6 | 0.9 | 1.4 | 1.1 | |
Avg P/E ratio | x | 16.1 | 10.4 | 11.6 | 23.5 | 14.9 | |
P/CF ratio (eoy) | x | 10.2 | 6.6 | 8.6 | 13.9 | 10.3 | |
Price / Book Value ratio | x | 1.6 | 1.1 | 1.7 | 2.1 | 1.8 | |
Dividend payout | % | 6.3 | 7.4 | 7.9 | 11.8 | 7.5 | |
Avg Mkt Cap | Rs m | 455 | 337 | 621 | 836 | 834 | |
Total wages/salary | Rs m | 76 | 91 | 96 | 123 | 139 |
MERCURY LAB. INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 555 | 573 | 686 | 579 | 753 | |
Other income | Rs m | 10 | 9 | 9 | 8 | 17 | |
Total revenues | Rs m | 566 | 581 | 695 | 587 | 771 | |
Gross profit | Rs m | 57 | 62 | 96 | 71 | 86 | |
Depreciation | Rs m | 16 | 19 | 19 | 25 | 25 | |
Interest | Rs m | 11 | 8 | 6 | 4 | 4 | |
Profit before tax | Rs m | 41 | 43 | 79 | 50 | 75 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 12 | 11 | 26 | 15 | 19 | |
Profit after tax | Rs m | 28 | 32 | 53 | 36 | 56 | |
Gross profit margin | % | 10.3 | 10.8 | 14.0 | 12.3 | 11.4 | |
Effective tax rate | % | 30.0 | 25.4 | 32.5 | 29.3 | 25.5 | |
Net profit margin | % | 5.1 | 5.6 | 7.8 | 6.1 | 7.4 |
MERCURY LAB. BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 319 | 315 | 378 | 352 | 417 | |
Current liabilities | Rs m | 169 | 151 | 188 | 157 | 164 | |
Net working cap to sales | % | 27.0 | 28.7 | 27.6 | 33.6 | 33.6 | |
Current ratio | x | 1.9 | 2.1 | 2.0 | 2.2 | 2.5 | |
Inventory Days | Days | 7 | 7 | 6 | 9 | 7 | |
Debtors Days | Days | 126,804,362 | 115,611,843 | 1,199 | 1,055 | 1,035 | |
Net fixed assets | Rs m | 254 | 248 | 276 | 272 | 259 | |
Share capital | Rs m | 12 | 12 | 12 | 12 | 12 | |
"Free" reserves | Rs m | 278 | 308 | 357 | 391 | 444 | |
Net worth | Rs m | 290 | 320 | 369 | 403 | 456 | |
Long term debt | Rs m | 85 | 63 | 62 | 25 | 24 | |
Total assets | Rs m | 573 | 563 | 654 | 624 | 676 | |
Interest coverage | x | 4.7 | 6.3 | 13.3 | 12.3 | 21.7 | |
Debt to equity ratio | x | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 | |
Sales to assets ratio | x | 1.0 | 1.0 | 1.0 | 0.9 | 1.1 | |
Return on assets | % | 6.8 | 7.2 | 9.1 | 6.4 | 8.8 | |
Return on equity | % | 9.8 | 10.1 | 14.5 | 8.8 | 12.2 | |
Return on capital | % | 13.7 | 13.4 | 19.8 | 12.8 | 16.3 | |
Exports to sales | % | 26.7 | 16.3 | 1.0 | 16.5 | 25.3 | |
Imports to sales | % | 1.9 | 0.1 | 0.4 | 0 | 0.4 | |
Exports (fob) | Rs m | 148 | 93 | 7 | 95 | 191 | |
Imports (cif) | Rs m | 11 | 0 | 3 | 0 | 3 | |
Fx inflow | Rs m | 148 | 93 | 7 | 95 | 191 | |
Fx outflow | Rs m | 11 | 1 | 3 | 1 | 8 | |
Net fx | Rs m | 137 | 93 | 4 | 95 | 183 |
MERCURY LAB. CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 52 | 55 | 82 | 52 | 25 | |
From Investments | Rs m | -50 | -11 | -46 | -19 | -11 | |
From Financial Activity | Rs m | -25 | -33 | -12 | -12 | -10 | |
Net Cashflow | Rs m | -23 | 10 | 24 | 21 | 4 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Divyakant R Zaveri | COMP SEC: Kinjal Khandelwal | YEAR OF INC: 1982 | BSE CODE: 538964 | FV (Rs): 10 | DIV YIELD (%): 0.4 |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare MERCURY LAB. With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.